Related Experiment Videos
[Magnesium and bronchopulmonary dysplasia]
1Department of Pediatrics A, Schneider Children's Medical Center of Israel, Petach Tikva.
Harefuah
|May 30, 2013
Summary
Magnesium levels may impact bronchopulmonary dysplasia (BPD) in premature infants. Low magnesium (hypomagnesemia) might contribute to BPD development by increasing inflammation and oxidative stress.
Area of Science:
- Neonatology
- Pulmonology
- Biochemistry
Context:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants requiring mechanical ventilation and oxygen.
- BPD is characterized by persistent respiratory symptoms, hypoxemia, and abnormal chest radiographs at 36 weeks gestational age.
- Proinflammatory cytokines and impaired angiogenesis contribute to BPD pathogenesis, exacerbated by postnatal hyperoxia.
Purpose:
- To investigate the unclear role of magnesium in the development of bronchopulmonary dysplasia (BPD).
- To explore the association between magnesium levels and respiratory outcomes in premature infants.
Summary:
- High magnesium levels at birth were linked to respiratory distress syndrome (RDS), pulmonary interstitial emphysema, respiratory failure, and BPD.
- Low magnesium intake is associated with reduced lung function; hypomagnesemia is found in acute pulmonary diseases and preterm neonates with RDS.
- Experimental hypomagnesemia induces inflammation, oxidative damage, and altered gene expression related to cell cycle, apoptosis, and remodeling, processes implicated in BPD.
Impact:
- Findings suggest hypomagnesemia may be a contributing factor to BPD pathogenesis.
- Understanding magnesium's role could inform novel therapeutic strategies for preventing or treating BPD.
- This research highlights the potential importance of monitoring and managing magnesium levels in high-risk infants.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:05Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...